The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Preliminary Safety and Clinical Observations From 4D pharma’s Phase I/II Study of MRx0518 in Combination With KEYTRUDA®
Clinical & Manufacturing

Preliminary Safety and Clinical Observations From 4D pharma’s Phase I/II Study of MRx0518 in Combination With KEYTRUDA®

NOV 21, 2019
Cognate BioServices announces acquisition of Cobra Biologics
Finance

Cognate BioServices announces acquisition of Cobra Biologics

NOV 21, 2019
Beware probiotics in ICU patients
Biotics and Supplements

Beware probiotics in ICU patients

NOV 20, 2019
BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD
Finance

BIOCODEX enters exclusive negotiations for the acquisition of Laboratoires IPRAD

NOV 20, 2019
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Biotics and Supplements

Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?

NOV 19, 2019
5-minute Microbiome Science Roundup: October 2019
Editor's Choice

5-minute Microbiome Science Roundup: October 2019

NOV 18, 2019
Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments
Pharma & Human Health

Doctors Come Together at FDA During C.diff Awareness Month, Advocate for Treatments

NOV 18, 2019
Arranta Bio announces the acquisition of Captozyme™, creating a Center for microbiome development and clinical supply
Finance

Arranta Bio announces the acquisition of Captozyme™, creating a Center for microbiome development and clinical supply

NOV 15, 2019
J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease
Pharma & Human Health

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

NOV 14, 2019
EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema
Finance

EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema

NOV 13, 2019
Unknown Virus Discovered in Human Body
Infectious Disease & AMR

Unknown Virus Discovered in Human Body

NOV 13, 2019